Professional Documents
Culture Documents
On arrival at the ED, Mr. H was not following commands. He was opening his eyes spontaneously however not looking at the staff or following gaze, he
continues to use inappropriate words and abnormal slurring speech, GCS: 11. He was seen spontaneously moving all limbs; however, he was not noted to be
moving his left foot. His left leg showed significant bruising and the left ankle was swollen ++. His peripheral pulses were present x 4 limbs. Mr. H was
breathing spontaneously with a soft abdomen. Given his continued agitation, he received midazolam 2mg and a CT head was completed, which came back
negative for any abnormal findings. A bedside x-ray revealed a fracture to the left lateral malleolus.
1
NUR1 320 - Case Study
Clinical Reasoning Cycle (CRC)
Mr. H remained in RESUS. Thirty minutes later, he became so agitated and aggressive that a code white was called as he was grabbing the staff and
throwing punches at them. Midazolam 6mg and 2 mg Haldol IV was given and he continued to remain agitated and aggressive with staff. His vitals were
BP: 215/109; T: 37.3◦C axillary; HR: 136; RR:26; SpO2: 100% RASS +4. It was decided given the significant danger to the patient and staff as the patient
remained combative and severely agitated pulling at all his medical equipment and was not responsive to any verbal commands that Mr. H be intubated.
He underwent a rapid sequence intubation with propofol (150mg), midazolam (10mg), and succinylcholine (150mg). During intubation he became
hypotensive to 79/49 and hypoxic to 79% for 30 seconds. Neosynephrine 300mcg was administered, due to continued hypotension he was started on a
neosynephrine drip titrated to a MAP ≥65. He was placed on a ventilator on AC/VC; RR:15 PEEP 7, TV: 550 and placed on a propofol drip titrated to a
RASS 0/-1. A chest Xray confirmed placement of the ETT.
Mr. H was transferred to the ICU, where he was admitted under the primary admission diagnosis agitation not yet determined, rule out: delirium tremens,
hepatic encephalopathy, post ictal delirium. On admission to the ICU, an arterial line was placed to his left radial site, a triple lumen was placed to the right
jugular, a foley was inserted to monitor his ins and outs, and NGT was inserted, and admission order for bloods to be done included blood cultures, CHEM
10 and ABG including lactate TID; CBC, Coags, LFTs, CK DIE. A chest xray confirmed placement of NGT and the central line.
He was started on a loading dose of Keppra, Thiamine IV, Folic acid IV, multivitamin IV, CBGM QID with sliding scale Humulin R. He continued to
receive propofol titrated for a RASS 0/-1 and the neosynephrine was changed to a norepinephrine drip once the central line was confirmed titrated to a MAP
=>65.
He was also started on Ringer’s Lactate at 50 ml/h.
The next day an electroencephalogram (EEG) was done at bedside in the morning which came back negative, in the afternoon an MRI head was completed
which came back with mild chronic vascular atherosclerosis and mild bi-lateral frontal atrophy. His 6am bloods showed irregular findings for Mg2+: 0.50;
2
NUR1 320 - Case Study
Clinical Reasoning Cycle (CRC)
PO4- : 0.70 and orders for PRN electrolyte replacements were inputted. The day shift nurse ensured appropriate electrolyte replacements occurred.
What are some of your conclusions? Which additional therapies could we consider? Where could this case progress to? What are some of the risks to the
patient given the therapies started? What psychosocial concerns might you have for this patient and family? Use the clinical reasoning cycle below to
answer the above questions, and the highlighted prompts to guide your responses.
Collect Cues/ Information
Review current information by reading the above case (e.g. handover reports, patient history, patient charts, results of investigations and nursing/medical assessments
previously undertaken)
Organize the most important information here (you can choose to do this by body system if that helps).
Neurological:
On scene: agitation, incomprehensible speech (mumbling, slurred speech) with increased volume (shouting), possible fall (found on the bottom of his basement
stairs on the ground), unable to follow commands. Pt’s wife reports that pt was increasingly “forgetful, agitated, and aggressive” recently. Potential decrease in
alcohol consumption around 5 days prior (pt’s wife told pt to “quit drinking for good” to prevent her from leaving the home/relationship, pt drinks 2 bottles of
wine/day, previous hospitalization for alcohol overdose 1 year ago)
During ambulance transport: pt was combative (RASS +4), received midazolam IM 1 mg, response was RASS of +1 post-administration of midazolam.
ED (RESUS): GCS score of 11 (eyes opening spontaneously, not following commands but moving spontaneously, inappropriate words/incomprehensible speech
(slurred speech)). Not following gaze or directing gaze to staff. Received midazolam 2 mg IM for continued agitation. Remained agitated and became combative
30 minutes later; midazolam 6mg and 2 mg haldol IV, response was continued agitation and aggressive behavior (RASS +4) so pt was intubated. Underwent rapid
sequence intubation with propofol 150 mg, midazolam 10 mg, and succinylcholine 150 mg. Propofol drip titrated to a RASS 0/-1. CT head scan negative.
ICU: DDx: delirium tremens, hepatic encephalopathy, post ictal delirium. Started on loading dose of Keppra, Thiamine IV. Propofol drip titrated to a RASS 0/-1
continued. EEG negative. MRI revealed mild chronic vascular atherosclerosis and mild bi-lateral frontal atrophy.
Cardiovascular:
PMHx of HTN (Rx: enalapril) and Afib (Rx: pradaxa)
On scene: BP: 112/68, HR: 130 irregular
ED (RESUS): Peripheral pulses present x4 limbs. K+: 3.8 mmol/L, Troponin: 141 ng/L, CK: 4167 U/L. HR: 125/min irregular→136; BP: 140/85 (ED T1)→215/109 (ED
T2)→79/49 (intubation), neosynephrine 300 mcg administered, pt remained hypotensive so neosynephrine drip titrated to MAP ≥65 started.
ICU: left radial arterial line, right jugular triple lumen placed (placement confirmed with chest xray). Order for CK and Coags DIE. Neosynephrine drip titrated to
MAP ≥65 continued via central line. Started on ringer’s lactate 50 ml/h.
Respiratory:
On scene: RR: 22; SpO2 96%
ED (RESUS): Breathing spontaneously upon admission. ABG: pH:7.27; HCO3: 20; CO2:57; Serum lactate: 9.0. Underwent rapid sequence intubation (with propofol
150 mg, midazolam 10 mg, and succinylcholine 150 mg). RR: 21/min→26, SpO2 99% RA (ED T1)→100% (ED T2)→79% (intubation). ETT placement confirmed by
xray. Ventilator on AC/VC; RR:15 PEEP 7, TV: 550.
ICU: Order for ABG including lactate TID. Started on ringer’s lactate 50 ml/h.
Musculoskeletal:
PMHx of osteoporosis: (Rx: os-cal)
ED (RESUS): Pt not moving left foot, ecchymosis to left leg, left ankle edema, left lateral malleolus fracture revealed by bedside x-ray.
Gastrointestinal:
PMHx cirrhosis (Child-Pugh Class A).
ED (RESUS): Soft abdomen, pt weights 99 kg, ALT: 56 U/L, bilirubin total: 7 mmol/L
3
NUR1 320 - Case Study
Clinical Reasoning Cycle (CRC)
ICU: NG tube inserted; placement confirmed with chest xray. LFTs DIE.
Renal:
ED (RESUS): Creatinine: 152
ICU: Foley catheter inserted (in/out monitoring)
Endocrine & Metabolic:
PMHx of DM type 2 (Rx: metformin). Rx rosuvastatin (PMHx of dyslipidemia?)
ED (RESUS): A1C%: 9.1, random glucose: 7.7 mmol/L
ICU: Order for CBGM QID, sliding scale Humulin R
Hematological & Immune:
ED (RESUS): WBC: 25.1, platelets: 140, HgB: 141 g/L, HcT: 0.52
ICU: Order for blood culture. CBC and Coags DIE.
Multi-system/other:
On scene: T: 37◦C axillary
ED (RESUS) Mg2+: 1.32 mmol/L, Na+: 140 mmol/L, PO4: 1.04 mmol/L, T: 37.3◦C axillary
ICU: Folic acid IV, multivitamin IV administered. Mg2+: 0.50; PO4- : 0.70. Electrolyte replacement administered. CHEM 10 DIE
Functional assessment & Social Hx:
Retired. Tobacco: 12.5 packs/year. Alcohol: 2 bottles of wine/day (previous hospitalization for alcohol overdose 1 year ago). Conflict between pt and wife 5 days
ago surrounding pt’s alcohol consumption, pt became violent (threw plates). Police called to scene by neighbors who heard “yelling and crashing” sound. Pt’s
wife refused to press charges. Pt’s wife reported pt “neglecting himself” and that pt’s role functioning at home has declined. Couple’s financial health affected by
pt’s tobacco and alcohol consumption as per pt’s wife. Pt’s wife told pt to “quit drinking for good” to prevent her from leaving the home/relationship.
Gather new information (e.g. undertake patient assessment)
What additional information would you like to know and why?
What are the patient's current ABG and lactate levels? It's important to understand if the patient still exhibits mixed metabolic/respiratory acidosis and to
evaluate for hypoperfusion. Additionally, what is the patient's current oxygen saturation (SpO2)? This information is important for potentially adjusting
ventilator settings to enhance brain perfusion, especially considering the patient's neurological symptoms.
An urgent electrocardiogram (ECG) should be obtained due to the patient's elevated Troponin levels (141 ng/L) and CK levels (4167 U/L), suggestive of MI (if not
already on continuous cardiac monitoring). Previous troponin and CK levels and any abnormal ECG findings (i.e. anything other than sinus rythym or Afib as he is
already known for Afib so this would be expected) should be reported to MD. Additionally, other causes for elevated troponin and CK should be explored if no
evidence of (N)STEMI is found (e.g. MI type II).
Has the patient decreased alcohol consumption following the recent conflict with their wife 5 days ago? This information is crucial to assess the potential
contribution of delirium tremens to the patient's symptoms, findings, and behaviors as 3 delirium tremens usually occurs within 48-96 hours of withdrawal
(Hoffman & Weinhouse, 2024).
Did the pt’s wife or anyone else observe signs of a seizure leading up to the pt’s hospitalization? This is important to assess post ictal delirium, in case someone
witnessed any signs of a seizure.
Did the pt’s wife notice any sx of alcohol withdrawal in the 5 days leading up to pt’s hospitalization (nausea/vomiting, tremor, sweating, anxiety, reported
perceptual (tactile/auditory/visual) disturbances, headache, disorientation)? This is important to assess whether delirium tremens could explain some of the pt’s
sx, findings and behaviors.
Did the patient's wife notice a gradual/insidious or sudden/acute onset of the patient's behavioral changes and symptoms? Understanding the timeline and
progression of symptoms would help to distinguish between conditions like hepatic encephalopathy, which typically has a gradual onset.
I would like to review the MRI imaging findings to see what the pattern of frontal atrophy to see whether there is a “knife edge pattern” that is characteristic of
frontal dementia (Peet et al., 2021). Also, it would be interesting to read the radiology report to see if there are any areas of ischemia that could contribute to
4
NUR1 320 - Case Study
Clinical Reasoning Cycle (CRC)
dementia (frontotemporal, vascular dementia etc) (Pluta, 2022).
Current neurological assessment, including Glasgow Coma Scale (GCS), pupillary response, and other pertinent assessments, is necessary to monitor neurological
status and guide treatment decisions.
We could recommend obtaining the pt’s ammonemia levels (ideally arterial ammonemia) as hyperammonemia would contribute to hepatic encephalopathy, and
we could recommend lactulose if has hyperammonemia (Mandiga et al., 2023). Assessment of bowel habits would be important, as constipation can increase
ammonia levels and exacerbate hepatic encephalopathy (Wolf, 2020). Lactulose could additionally help treat or prevent constipation.
What are the results of the LFTs? INR? Does the pt have ascites? What is pt’s current child pugh score or class? This would help us understand pt’s liver
functioning.
Does the pt show any signs of pain (tense or grimacing facial expression, protection or restless movements, muscle tension)? What is the pt’s CPOT score? This
would help us assess the pt’s pain given his left lateral malleolus fracture.
Given that the pt’s creatinine level was elevated upon admission, which would indicate an alteration in renal functioning, I would like to know the pt’s in and
outs. Is there decreased urine output? We could also recommend obtaining the pt’s BUN levels to further assess renal functioning.
Given the pt’s elevated WBC count, I would like to know the results of the blood culture, his current temperature, and I would like to assess for any other
signs/sx of infection.
What supports does the pt’s wife/family need at this time? This could help create a collaborative partnership with the pt/family to optimize pt care.
5
NUR1 320 - Case Study
Clinical Reasoning Cycle (CRC)
Interpret: analyse data to come to an understanding of signs or symptoms; compare normal vs abnormal.
What information do you feel is normal and abnormal (and why)?
8
NUR1 320 - Case Study
Reflect on Process
Reflect what you have learnt from this process and what you could have done differently. Reflect on how this was guided by or how you can integrate Strengths-Based
Nursing and Healthcare into this process. Consider how interprofessional communication and teamwork would support this process. Reflect on the potential impact of
stigmatization surrounding alcohol-related conditions on this process. Share your thoughts based on these leading statements.
I have learned about the many ways that one disorder (possible AUD) can give rise to numerous pathologies, potentially manifesting simultaneously. Reflecting on this
experience, I would adopt a different approach to the CRC process in the future. Instead of presuming a singular underlying pathology, I would try to consider the
possibility of various contributing processes to mitigate bias bias when trying to interpret the information. Likewise, interprofessional communication and teamwork was
important to support this process as this case required a multifaceted approach. From a SBN lens, it was very evident that the person integral SBN value was of utmost
importance in this case (Gottlieb, 2014). The patient was shaped by his environment and relationship (Gottlieb, 2014). Also, it was extremely important to create a
collaborative partnership with the spouse to understand the case and optimize care for the patient (Gottlieb, 2014). This case also allowed me to reflect on the potential
impact of stigmatization surround alcohol-related conditions. I found myself questioning why the patient hadn't received adequate treatment for AUD following their last
hospitalization or continued prophylaxis like thiamine. This made me reflect on my own experience as a nurse, and I have noticed that patients with AUD are often quick
to be dismissed, especially if they do not show readiness to change. This deficit-based approach not only overlooks opportunities for preventive healthcare but also
exacerbates future health complications, ultimately resulting in higher costs to the healthcare system. As a nurse, it prompts me to advocate for more holistic and
proactive approaches to care, ensuring that individuals with AUD receive the support and interventions they need for better long-term outcomes.
I have cared with patients with alcohol withdrawal syndrome, sometimes exhibiting altered levels of consciousness and impaired speech. I have learned from this case
that it is important to take a proactive approach to gathering data rather than passively waiting for the patient to regain communicative abilities. This is important for
optimizing treatment efficacy and mitigating the risk of severe complications such as delirium tremens. One valuable lesson learned from this case is the importance of
gathering information as early as possible. Instead of solely relying on the patient's ability to communicate their alcohol consumption history, it’s important to seek
collateral information from family members, friends, or caregivers, if available. By doing so, the nurse can gain crucial insights into the patient's alcohol consumption
patterns and anticipate potential life-threatening complications such as delirium tremens. By taking a proactive approach appropriate interventions tailored to the
patient's specific needs can be initiated earlier. Early identification of risk factors for severe withdrawal symptoms enables healthcare providers to implement preventive
measures and provide timely pharmacological interventions, ultimately enhancing patient outcomes and minimizing the likelihood of adverse events.
9
NUR1 320 - Case Study
References
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., Gilard, M.,
Hinterbuchner, L., Jankowska, E. A., Jüni, P., Kimura, T., Kunadian, V., Leosdottir, M., Lorusso, R., Pedretti, R. F. E., … ESC Scientific
Document Group. (2023). 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the
management of acute coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal, 44(38), 3720–3826.
https://doi.org/10.1093/eurheartj/ehad191
Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed). (2013). American Psychiatric Association, American Psychiatric Association.
http://www.PsychiatryOnline.org
Hoffman, R. S., & Weinhouse, G. (2024). Management of moderate and severe alcohol withdrawal syndromes. In E. Schwarz (Ed.), UpToDate.
syndromes#H21
Mandiga, P., Foris, L. A., & Bollu, P. C. (2024). Hepatic Encephalopathy. In StatPearls. StatPearls Publishing.
http://www.ncbi.nlm.nih.gov/books/NBK430869/
Peet, B. T., Spina, S., Mundada, N., & La Joie, R. (2021). Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with
10
NUR1 320 - Case Study
Pluta, R. (2022). Ischemic Brain Neurodegeneration. International Journal of Molecular Sciences, 23(12), 6441.
https://doi.org/10.3390/ijms23126441
Ranasinghe, I. R., Sharma, B., & Bashir, K. (2024). Hepatorenal Syndrome. In StatPearls. StatPearls Publishing.
http://www.ncbi.nlm.nih.gov/books/NBK430856/
Sabayan, B., Goudarzi, R., Ji, Y., Borhani‐Haghighi, A., Olson‐Bullis, B. A., Murray, A. M., & Sedaghat, S. (2023). Intracranial Atherosclerosis
Disease Associated With Cognitive Impairment and Dementia: Systematic Review and Meta ‐Analysis. Journal of the American Heart
Tsoris, A., & Marlar, C. A. (2024). Use Of The Child Pugh Score In Liver Disease. In StatPearls. StatPearls Publishing.
http://www.ncbi.nlm.nih.gov/books/NBK542308/
11
NUR1 320 - Case Study